Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis
Date
2011
Authors
Granich R.
Lo Y.-R.
Suthar A.B.
Vitoria M.
Baggaley R.
Obermeyer C.M.
McClure C.
Souteyrand Y.
Perriens J.
Kahn J.G.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
Keywords
antiretrovirus agent, emtricitabine plus tenofovir disoproxil, tenofovir, acquired immune deficiency syndrome, antiviral therapy, CD4 lymphocyte count, clinical trial (topic), community care, disease transmission, drug withdrawal, highly active antiretroviral therapy, HIV education, HIV test, human, Human immunodeficiency virus infection, human rights, mathematical model, meta analysis (topic), multicenter study (topic), patient counseling, randomized controlled trial (topic), review, risk assessment, tuberculosis
Citation
Current HIV Research
9
6
http://www.scopus.com/inward/record.url?eid=2-s2.0-80055099681&partnerID=40&md5=5e15179f0ac06dea9fbf72af28c54ba0
9
6
http://www.scopus.com/inward/record.url?eid=2-s2.0-80055099681&partnerID=40&md5=5e15179f0ac06dea9fbf72af28c54ba0